Vismodegib, marketed under the brand name Erivedge, is a targeted therapy drug used in the treatment of certain types of cancer. It is particularly utilized for treating adults with advanced basal cell carcinoma (BCC) that has either metastasized (spread to other parts of the body) or cannot be treated with surgery or radiation.
